IL17A and asthma: Finally, we tested the effect of Inhaled Corticosteroids (ICS) and long-actingβ2agonists (LABA) in both an in vitro and in vivo approach in order to provide new therapeutic strategies to control the inflammation associated with Th17 producing IL-17A in children with AR and concomitant asthma.